These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group]. Skoczen S, Klus K, Armata J, Kowalczyk J, Wisniewska-Slusarz H, Kolecki P, Derwich K, Matysiak M, Krauze A, Rokicka-Milewska R, Pawelec K, Boguslawska-Jaworska J, Juszczak K, Pisarek J, Sońta-Jakimczyk D, Tomaszewska R, Łuszczynska A, Wysocki M, Styczyński J. Med Wieku Rozwoj; 2000; 4(1 Suppl 2):23-32. PubMed ID: 12021459 [Abstract] [Full Text] [Related]
7. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol. Güneş AM, Oren H, Baytan B, Bengoa SY, Evim MS, Gözmen S, Tüfekçi O, Karapınar TH, Irken G. Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691 [Abstract] [Full Text] [Related]
8. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R, Riehm H, Schrappe M, Reiter A, BFM Group. Br J Haematol; 2005 Oct; 131(1):39-49. PubMed ID: 16173961 [Abstract] [Full Text] [Related]
14. Prediction of outcome by early response in childhood acute lymphoblastic leukemia. Möricke A, Lauten M, Beier R, Odenwald E, Stanulla M, Zimmermann M, Attarbaschi A, Niggli F, Schrappe M. Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057 [Abstract] [Full Text] [Related]
15. [Preliminary results of BFM 96 protocol in treatment of childhood ALL relapse in the experience of the Polish Paediatric Leukaemia /Lymphoma Study Group]. Chybicka A, Bogusławska-Jaworska J, Gorczyńska E, Armata J, Balcerska A, Balwierz W, Bubala H, Filiks-Litwin B, Kołecki P, Kowalczyk J, Łukowska K, Matysiak M, Rokicka-Milewska R, Rola-Kurc E, Stencel D, Sonta-Jakimczyk D, Strojny W, Wachowiak J, Wieczorek M, Wysocki M, Zelenay E. Med Wieku Rozwoj; 2000 May; 4(1 Suppl 2):43-8. PubMed ID: 12021461 [Abstract] [Full Text] [Related]
17. [Treatment results with ALL-BFM-95 protocol in children with acute lymphoblastic leukemia in Hungary]. Müller J, Kovács G, Jakab Z, Rényi I, Galántai I, Békési A, Kiss C, Nagy K, Kajtár P, Bartyik K, Masát P, Magyarosy E. Orv Hetil; 2005 Jan 09; 146(2):75-80. PubMed ID: 15724956 [Abstract] [Full Text] [Related]
18. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center. Mora J, Filippa DA, Qin J, Wollner N. Cancer; 2003 Sep 15; 98(6):1283-91. PubMed ID: 12973853 [Abstract] [Full Text] [Related]
19. [Twenty years of treating childhood acute lymphoblastic leukemia]. Pérez Martínez A, Alonso Ojembarrena A, Ramírez Orellana M, García Castro J, González-Vicent M, Contra Gómez T, Madero López L, Díaz Pérez MA. An Pediatr (Barc); 2006 Sep 15; 65(3):198-204. PubMed ID: 16956497 [Abstract] [Full Text] [Related]